Shaanxi Kanghui Pharmaceutical Co. , Ltd. Class ASSE: 603139

"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Convening the 2026 Semi-annual Performance Briefing

Sep 18, 2026 · Issued by Shaanxi Kanghui Pharmaceutical Co. , Ltd. Class A via Shanghai Stock Exchange

Announcement on Convening the 2026 Semi-annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Shaanxi Kanghui Pharmaceutical Co. , Ltd. Class A

"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Procurement of High-performance Computing Servers and Signing of Computing Power Service Contract by Wholly-owned SubsidiarySep 17
"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Shareholding Reduction Plan by Shareholders Holding More Than 5% of the Shares and DirectorsSep 16
"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 5th Extraordinary General Meeting in 2026Sep 8
"SHAANXI KANGHUI PHARMACEUTICAL CO., LTD."Announcement on Completion of Shareholding Reduction Plan by Shareholder Holding More Than 5% of the Shares and Results of Shareholding ReductionSep 2

All Shaanxi Kanghui Pharmaceutical Co. , Ltd. Class A news releases